Literature DB >> 18201552

Identification and functional analysis of CBLB mutations in type 1 diabetes.

Norihide Yokoi1, Yuuka Fujiwara, He-Yao Wang, Mai Kitao, Chihiro Hayashi, Tomohiro Someya, Masao Kanamori, Yutaka Oiso, Naoko Tajima, Yuichiro Yamada, Yutaka Seino, Hiroshi Ikegami, Susumu Seino.   

Abstract

Casitas B-lineage lymphoma b (Cblb) is a negative regulator of T-cell activation and dysfunction of Cblb in rats and mice results in autoimmunity. In particular, a nonsense mutation in Cblb has been identified in a rat model of autoimmune type 1 diabetes. To clarify the possible involvement of CBLB mutation in type 1 diabetes in humans, we performed mutation screening of CBLB and characterized functional properties of the mutations in Japanese subjects. Six missense mutations (A155V, F328L, N466D, K837R, T882A, and R968L) were identified in one diabetic subject each, excepting N466D. Of these mutations, F328L showed impaired suppression of T-cell activation and was a loss-of-function mutation. These data suggest that the F328L mutation is involved in the development of autoimmune diseases including type 1 diabetes, and also provide insight into the structure-function relationship of CBLB protein.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18201552     DOI: 10.1016/j.bbrc.2008.01.032

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Cbl exposes its RING finger.

Authors:  Stephen C Kales; Philip E Ryan; Stanley Lipkowitz
Journal:  Nat Struct Mol Biol       Date:  2012-02-03       Impact factor: 15.369

2.  Myostatin induces insulin resistance via Casitas B-lineage lymphoma b (Cblb)-mediated degradation of insulin receptor substrate 1 (IRS1) protein in response to high calorie diet intake.

Authors:  Sabeera Bonala; Sudarsanareddy Lokireddy; Craig McFarlane; Sreekanth Patnam; Mridula Sharma; Ravi Kambadur
Journal:  J Biol Chem       Date:  2014-01-22       Impact factor: 5.157

3.  Ubiquitin-Dependent Regulation of Treg Function and Plasticity.

Authors:  Yi Dong; Fan Pan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Autoinhibition and phosphorylation-induced activation mechanisms of human cancer and autoimmune disease-related E3 protein Cbl-b.

Authors:  Yoshihiro Kobashigawa; Akira Tomitaka; Hiroyuki Kumeta; Nobuo N Noda; Masaya Yamaguchi; Fuyuhiko Inagaki
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-07       Impact factor: 11.205

Review 5.  Genetic associations in type I interferon related pathways with autoimmunity.

Authors:  Angélica M Delgado-Vega; Marta E Alarcón-Riquelme; Sergey V Kozyrev
Journal:  Arthritis Res Ther       Date:  2010-04-14       Impact factor: 5.156

6.  Pid1 induces insulin resistance in both human and mouse skeletal muscle during obesity.

Authors:  Sabeera Bonala; Craig McFarlane; Jackie Ang; Radiance Lim; Marcus Lee; Hillary Chua; Sudarsanareddy Lokireddy; Patnam Sreekanth; Melvin Khee Shing Leow; Khoo Chin Meng; Tai E Shyong; Yung Seng Lee; Peter D Gluckman; Mridula Sharma; Ravi Kambadur
Journal:  Mol Endocrinol       Date:  2013-08-08

7.  Signature RNAS and related regulatory roles in type 1 diabetes mellitus based on competing endogenous RNA regulatory network analysis.

Authors:  Qinghong Shi; Hanxin Yao
Journal:  BMC Med Genomics       Date:  2021-05-18       Impact factor: 3.063

8.  Diubiquitin (Ubd) is a susceptibility gene for virus-triggered autoimmune diabetes in rats.

Authors:  L Cort; M Habib; R A Eberwine; M J Hessner; J P Mordes; E P Blankenhorn
Journal:  Genes Immun       Date:  2014-01-23       Impact factor: 2.676

Review 9.  Involvement of Cbl-b-mediated macrophage inactivation in insulin resistance.

Authors:  Tomoki Abe; Katsuya Hirasaka; Takeshi Nikawa
Journal:  World J Diabetes       Date:  2017-03-15

10.  Molecular mechanisms of insulin resistance in chronic kidney disease.

Authors:  Sandhya S Thomas; Liping Zhang; William E Mitch
Journal:  Kidney Int       Date:  2015-10-07       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.